Top Markets
Coin of the day
Changchun BCHT Biotechnology Co. Changchun BCHT Biotechnology Co.

Changchun BCHT Biotechnology Co.

688276
Rank in Stocks #9482
Changchun BCHT Biotechnology Co. Ltd. is a biopharmaceutical enterprise... Changchun BCHT Biotechnology Co. Ltd. is a biopharmaceutical enterprise primarily focused on the research, development, production, and global commercialization of vaccines designed for human use. Its extensive product portfolio features key immunizations such as attenuated (live) herpes zoster and varicella vaccines, alongside a live, nasal, and freeze-dried influenza vaccine, and a rabies vaccine utilizing vero cell technology. This company was established in 2004 and is headquartered in Changchun, China.
Share Price
$2.43
Last synced: 2026-08-28
Market Cap
$1.01B
Change (1 day)
-4.99%
Change (1 year)
-27.49%
Country
CN
Trade Changchun BCHT Biotechnology Co. (688276)

Category

Revenue for Changchun BCHT Biotechnology Co. (688276)
Revenue in Aug 2026 TTM: 0
According to Changchun BCHT Biotechnology Co. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Changchun BCHT Biotechnology Co. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors